CAS: 2376577-06-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | M2N12 REF: 54-BUP05516CAS: 2376577-06-7 | ≥98% | 704.00 €~1,403.00 € | Tue 06 May 25 |
 | M2N12 REF: TM-T11929CAS: 2376577-06-7 | 98.01% | 88.00 €~1,035.00 € | Mon 12 May 25 |
 | M2N12 REF: 3D-BVD57706CAS: 2376577-06-7 | Min. 95% | 331.00 €~1,847.00 € | Mon 16 Jun 25 |
Ref: 54-BUP05516
| 25mg | 704.00 € | ||
| 50mg | 1,039.00 € | ||
| 100mg | 1,403.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
M2N12
CAS:2376577-06-7
M2N12 selectively inhibits Cdc25C (IC50=0.09μM) and has anti-tumor properties, affecting Cdc25A and B as well.
Formula:
C20H16ClN5O2
Purity:
98.01%
Color and Shape:
Solid
Molecular weight:
393.83
Ref: TM-T11929
| 1mg | 88.00 € | ||
| 5mg | 160.00 € | ||
| 10mg | 250.00 € | ||
| 25mg | 472.00 € | ||
| 50mg | 707.00 € | ||
| 100mg | 1,035.00 € | ||
| 1mL*10mM (DMSO) | 170.00 € |
Estimated delivery in United States, on Monday 12 May 2025
M2N12
CAS:2376577-06-7
Please enquire for more information about M2N12 including the price, delivery time and more detailed …
Formula:
C20H16ClN5O2
Purity:
Min. 95%
Molecular weight:
393.8 g/mol
Ref: 3D-BVD57706
| 1mg | 331.00 € | ||
| 5mg | 484.00 € | ||
| 10mg | 690.00 € | ||
| 25mg | 1,155.00 € | ||
| 50mg | 1,847.00 € |
Estimated delivery in United States, on Monday 16 Jun 2025
